SG

Salvatore Giovine

CFO Innovative Medicine BD & EI at Johnson & Johnson

Salvatore Giovine has an extensive background in finance and has held various roles at Johnson & Johnson, Xilio Therapeutics, Inc., Deloitte, and Clifford Chance. Salvatore currently serves as the CFO Innovative Medicine BD & EI at Johnson & Johnson. Salvatore holds an MBA in Corporate Finance from Fordham Gabelli School of Business and a B.S. in Accounting from the same institution.

Links